The graphic shows October vaccine-preventable disease hot spots for nine diseases: chicken pox, diphtheria, hepatitis A, hepatitis B, measles, mumps, polio, RSV, and whooping cough. (Allison Krugman/Think Global Health) |
Cuts to foreign aid, growing vaccine hesitancy, and persistent gaps in vaccine access are fueling outbreaks of vaccine-preventable diseases around the world, in poor and wealthy nations alike. In partnership with the International Society for Infectious Diseases, Think Global Health launched a dashboard to monitor outbreaks around the world of nine diseases featured in the Centers for Disease Control and Prevention’s routine immunization schedule. It will be updated weekly and covers 2000 to 2025. View the dashboard
|
|
|
Employees work on a production line manufacturing cold-medicine products amid the COVID-19 outbreak, during an organized media tour at Youcare Pharmaceutical Group in Beijing, China. (Tingshu Wang/Reuters) |
The years-long drug cooperation impasse between the U.S. and China harms both nations and the world, and the stakes in global health security could not be higher. In the South China Morning Post, CFR Senior Fellow Huang highlights how American and Chinese mechanisms for public health cooperation and disease surveillance have collapsed and makes the case for why rebuilding that cooperation between the two countries on public health is critical. Read the full article
|
|
|
Prashant Yadav, Chloe Searchinger |
A nurse administers a malaria vaccine to an infant at the health center in Datcheka, Cameroon. (Desire Danga Essigue/Reuters) |
Malaria claims nearly six hundred thousand lives per year worldwide—and children under five years old account for almost three-quarters of those deaths. Yet providing convenient, child-friendly treatment has remained a challenge, particularly for infants. Writing for Think Global Health, Senior Fellow Yadav and Research Associate Searchinger celebrate the newly released Coartem Dispersible, the first approved malaria drug for newborns and infants, while outlining the challenges that will hinder the medicine’s deployment. Explore the full article
|
|
|
Stephanie Psaki, Prashant Yadav, Elena Every, Thomas J. Bollyky |
A stack of medical supplies provided by the U.S. Agency for International Development (USAID) is seen outside the Bauchi State Drugs and Medical Consumables Management Agency central medical store in Bauchi State, Nigeria. (Sodiq Adelakun/Reuters) |
The U.S. State Department’s America First Global Health Strategy puts forward an affirmative vision of U.S. global health engagement, consistent with President Donald Trump’s America First priorities. In this Think Global Health piece, former U.S. Coordinator for Global Health Security Stephanie Psaki, Yadav, Research Associate Every, and Senior Fellow Bollyky—who is CFR’s Bloomberg chair in global health and directs its Global Health program—highlight some of the obstacles the State Department and Congress will face when implementing the strategy. Read more
|
|
|
Although the delicate Gaza ceasefire deal could secure long-awaited peace and launch a new era of Palestinian governance, two years of war have already wrought unconscionable human suffering for civilians, yielding tens of thousands of deaths, disease outbreaks, and a shattered health system. For Think Global Health, Associate Editor Krugman offers three charts to recount what has unfolded since the October 7 attack and to take stock of the immense health needs in Gaza. Explore the article
|
|
|
More on Global Health From CFR |
| |
Think Global Health is a multi-contributor website that examines the ways in which changes in health are reshaping economies, societies, and the everyday lives of people worldwide. |
| |
|
CFR Events on Global Health |
The Resurgence of Vaccine Preventable Diseases at Home and Abroad, With Bollyky; Seth Berkley, Former CEO of Gavi; Heidi Larson, Director of the Vaccine Confidence Project, and Professor of Anthropology, Risk, and Decision Science at the London School of Hygiene and Tropical Medicine; and William Moss, Executive Director of the International Vaccine Access Center and Professor of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health
Improving Resiliency in the U.S. Pharmaceutical Supply Chain Through Make-Buy-Invest Strategic Actions, With Bollyky and Yadav; Melanie Hart, Senior Director of the Atlantic Council’s Global China Hub and Former Senior Advisor for China in the Office of the Undersecretary for Economic Growth, Energy, and the Environment; and Tim Manning, Professor in Georgetown University’s Center for Global Health Science and Security and Former Deputy Administrator of the Federal Emergency Management Agency for Protection and National Preparedness
|
| |
About the Global Health Program |
|
|
|
